| Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673) |
|---|
| 01/20/2011 | US20110015194 Quinoxalinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes |
| 01/20/2011 | US20110015158 Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties |
| 01/19/2011 | EP2275414A1 Cyclopentylacrylic acid amide derivative |
| 01/19/2011 | CN1816543B Indole derivatives with apoptosis-inducing effect |
| 01/19/2011 | CN101952258A Quinoxalinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes |
| 01/19/2011 | CN101948366A Method for preparing 4-(diphenylamino)biaryl compound in water phase |
| 01/18/2011 | US7872139 Heteroaryl-ureas and their use as glucokinase activators |
| 01/18/2011 | US7872130 3'-N,N-dimethylamino-3,8'-dimethyl-8-(N-methylamino)-7'-oxo-10,5'-diphenyl-5',7'-dihydro-[2,2']biphenazinyl-10-ium chloride; copper plating bath for bright, ductile copper coating, contains as an additive a mixture of oligomeric phenazinium compound (containing two and three monomeric units) |
| 01/18/2011 | US7872017 such as 5-{5-[(endo)-8-methyl-8-aza-bicyclo[3.2.1]oct-3-yloxy]-pyridin-2-yl}-1H-indole, having nicotinic receptors modualtory activity, used for the treatment of attention deficit disorder, senile dementia, Down's syndrome, amyotrophic lateral sclerosis, Huntington's, Pick's and Alzheimer's disease |
| 01/13/2011 | WO2011005731A2 Process for making cgrp receptor antagonist |
| 01/13/2011 | WO2011003423A1 Manufacture of 4-((1r,3s)-6-chloro-3-phenyl-indan-1-yl)-1,2,2-trimethyl-piperazine and 1-((1r,3s)-6-chloro-3-phenyl-indan-1-yl)-3,3-dimethyl-piperazine |
| 01/13/2011 | WO2010096384A3 Fused benzazepines as neuronal nicotinic acetylcholine receptor ligands |
| 01/13/2011 | US20110009622 Long-chain fatty acyl elongase inhibitor comprising arylsulfonyl derivative as active ingredient |
| 01/13/2011 | US20110009426 5,6-bisaryl-2-pyridine-carboxamide derivatives, preparation thereof and therapeutic application thereof as urotensin ii receptor antagonists |
| 01/13/2011 | US20110009423 Phenyl-piperazine derivatives as serotonin reuptake inhibitors |
| 01/13/2011 | US20110009420 Histamine H3 Receptor Ligands |
| 01/13/2011 | US20110009418 Therapeutic agents useful for treating pain |
| 01/13/2011 | US20110009371 Synthesis of tetracyclines and analogues thereof |
| 01/13/2011 | US20110008268 Phenyl substituted pyrazinoylguanidine sodium channel blockers possessing beta agonist activity |
| 01/13/2011 | CA2766607A1 Manufacture of 4-((1r,3s)-6-chloro-3-phenyl-indan-1-yl)-1,2,2-trimethyl-piperazine and 1-((1r,3s)-6-chloro-3-phenyl-indan-1-yl)-3,3-dimethyl-piperazine |
| 01/12/2011 | EP2272834A1 Benzoyl amino heterocyclyl compounds as glucokinase (GLK) activators |
| 01/12/2011 | EP2271632A1 3-trifluoromethyl-pyrazine-2-carboxylic acid amide derivatives as hdl-cholesterol raising agents |
| 01/12/2011 | EP2271622A2 Heteroaryl derivatives as cftr modulators |
| 01/12/2011 | EP2190827B1 N-benzyl-n'-arylcarbonylpiperazine derivatives as lxr modulators |
| 01/12/2011 | CN101945858A Pyrazinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes |
| 01/12/2011 | CN101945857A High dielectric constant liquid crystal |
| 01/12/2011 | CN101941947A Synthesis method of 2-chloro-6-chloroquinoxaline |
| 01/12/2011 | CN101941941A Carboxylic ester compound and applications thereof |
| 01/12/2011 | CN101941917A Amide compounds and use thereof |
| 01/11/2011 | US7868010 N-(3,5-diamino-6-chloropyrazine-2-carbonyl)-N-(4-{4-[3-(1H-tetrazol-5-yl)propoxy]phenyl}butyl)guanidine hydrochloride; absorbed less rapidly from mucosal surfaces, less reversible |
| 01/11/2011 | US7868006 chemokine receptor antagonists used for the therapy of inflammatory diseases, autoimmune diseases, transplant rejection, infectious diseases, ophthalmic inflammation, diabetes, meningitis, tumors and side effect reduction |
| 01/11/2011 | US7868005 Pyrazinyl substituted piperazine-piperidines with CXCR3 antagonist activity |
| 01/11/2011 | CA2534088C 2,3-substituted pryidl compounds useful for treating pain |
| 01/11/2011 | CA2492138C N-phenyl-(2r,5s)dimethylpiperazine derivative |
| 01/11/2011 | CA2461439C Novel .alpha.-oxygenated or .alpha.-thiolated carboxylic acid phenethylamide derivatives |
| 01/11/2011 | CA2451678C Azaindoles |
| 01/11/2011 | CA2449555C Hydroxylation of beta-dicarbonyls with zirconium catalysts |
| 01/11/2011 | CA2436891C Ortho-substituted nitrogen-containing bisaryl compounds used as potassium channel inhibitors |
| 01/06/2011 | WO2011002984A1 Substituted phenoxypropylcycloamine derivatives as histamine-3 (h3) receptor ligands |
| 01/06/2011 | WO2011002145A2 Absorbent for separating acid gas |
| 01/06/2011 | US20110003991 Piperazine derivatives and their use in controlling pests |
| 01/06/2011 | US20110003832 NEW CAPPED Pyrazinoylguanidine SODIUM CHANNEL BLOCKERS |
| 01/06/2011 | US20110003812 Human Adam-10 Inhibitors |
| 01/06/2011 | US20110003784 Opsin-binding ligands, compositions and methods of use |
| 01/06/2011 | US20110003759 Non-basic melanin concentrating hormone receptor-1 antagonists and methods |
| 01/06/2011 | US20110003691 Substituted Pyrazinylmethyl Sulfonamides For Use As Fungicides |
| 01/06/2011 | US20110003395 Specific analysis of analytes using reagent compounds, labeling strategies, and mass spectrometry workflow |
| 01/06/2011 | CA2766873A1 Therapeutic compositions and related methods of use |
| 01/05/2011 | EP2270006A1 Pyridazine derivatives useful as vanilloid receptor ligands |
| 01/05/2011 | EP2268624A1 Arylpyrazinone derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes |
| 01/05/2011 | EP2268608A2 Stabilized nucleic acid dark quencher-fluorophore probes |
| 01/05/2011 | EP1542692B1 Aminopyrimidine derivatives for use as vanilloid receptor ligands for the treatment of pain |
| 01/05/2011 | CN101939304A Process for making triphenylboron-pyridine compound |
| 01/05/2011 | CN101939054A Organic compounds |
| 01/05/2011 | CN101935306A New diketone piperazidine-like derivative and application thereof |
| 01/05/2011 | CN101935305A Trans-1(6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine |
| 01/04/2011 | US7863276 peroxisome proliferator activated receptors modulators such as (S)-4-[cis-2,6-dimethyl-4-(4-trifluoromethoxy-phenyl)-piperazine-1-sulfonyl]-indan-2-carboxylic acid tosylate, used for the treatment or prevention of non-insulin dependentdiabetes, hypercholesterolemia and inflammatory disorders |
| 01/04/2011 | CA2319672C Compounds and compositions for delivering active agents |
| 12/30/2010 | US20100331540 Method for producing compound having deuterated aromatic ring or heterocyclic ring |
| 12/30/2010 | US20100331329 Benzamide derivatives useful as histone deacetylase inhibitors |
| 12/30/2010 | US20100331328 Bicyclylaryl-aryl-amine compounds and their use |
| 12/30/2010 | US20100331234 Aminoalcohol lipidoids and uses thereof |
| 12/30/2010 | US20100330030 Vasculostatic Agents and Methods of Use Thereof |
| 12/30/2010 | US20100328600 Liquid crystal compound, liquid crystal composition and liquid crystal display device |
| 12/29/2010 | WO2010151006A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 12/29/2010 | WO2010150865A1 Crystals |
| 12/29/2010 | EP2265592A1 Substituted pyraz inylmethyl sulfonamides for use as. fungicides |
| 12/29/2010 | EP2265591A1 Nitrone compounds, process of preparation thereof, and use thereof in medicament manufacture |
| 12/29/2010 | EP1370530B1 Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical |
| 12/29/2010 | EP1001946B1 QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p56lck TYROSINE KINASES |
| 12/29/2010 | CN101932562A Carbamoyl compounds as dgat1 inhibitors 190 |
| 12/29/2010 | CN101928252A Preparation method of 3-methyl-2-ethanol based quinoxaline |
| 12/29/2010 | CA2764956A1 Novel biphenyl and phenyl-pyridine amides |
| 12/29/2010 | CA2764475A1 Crystals |
| 12/29/2010 | CA2762675A1 Heterocyclic antiviral compound |
| 12/23/2010 | WO2010146395A1 Pyrazine carboxamides as inhibitors of dgat1 |
| 12/23/2010 | WO2010145790A1 Propargyloxybenzamide derivatives |
| 12/23/2010 | WO2010088450A3 Arylamide derivatives useful in the treatment of diseases associated with serca activity |
| 12/23/2010 | US20100324291 Processes for 4-((1r,3s)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine or a salt thereof |
| 12/23/2010 | US20100324071 Novel glucokinase activators and methods of using same |
| 12/23/2010 | US20100324068 Chemical compounds 785 |
| 12/23/2010 | US20100324061 Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors |
| 12/23/2010 | US20100324056 Biphenyl and phenyl-pyridine amides as p2x3 and p2x2/3 antagonists |
| 12/23/2010 | US20100324046 4-carboxybenzylamino derivatives as histone deacetylase inhibitors |
| 12/23/2010 | US20100324042 Heterocyclic compounds and their use as glycogen synthase kinase 3 inhibitors |
| 12/23/2010 | US20100324025 Antibacterial Agents |
| 12/23/2010 | US20100323889 Herbicidal compounds |
| 12/23/2010 | CA2767895A1 Opsin-binding ligands, compositions and methods of use |
| 12/23/2010 | CA2764013A1 Pyrazine carboxamides as inhibitors of dgat1 |
| 12/22/2010 | EP2264030A1 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases |
| 12/22/2010 | EP2262780A2 Amorphous varenicline tartrate |
| 12/22/2010 | EP2061774B1 Arylpiperazine derivatives and uses thereof |
| 12/22/2010 | EP1513822B1 Lyotropic liquid crystal system and anisotropic film |
| 12/22/2010 | CN101921238A Preparation of substituted nitrogen-containing benzoheterocycle derivatives and pharmacological application thereof |
| 12/22/2010 | CN101921237A Method for preparing 4-ethyl-2,3-dioxypiperazine-1-formate |
| 12/22/2010 | CN101072779B 2,4 (4,6) pyrimidine derivatives |
| 12/21/2010 | US7855292 Cholecystokinin (CCK) receptor ligands; antagonists; 3-(5-Bromo-thiophen-2-yl)-2-[4-chloro-2-(quinoxaline-5-sulfonylamino)-benzoylamino]-propionic acid methy; pain, drug dependence, anxiety, panic attack, schizophrenia, pancreatic disorders, secretory disorders, ulcers, cancers; improved pharmacokinetics |
| 12/21/2010 | US7855208 cholinergic ligands such as (9-Methyl-3,9-diaza-bicyclo[3.3.1]non-3-yl)-[5-(4-nitro-phenyl)-furan-2-yl]-methanone, useful for the treatment of nervous system disorders, disorders related to smooth muscle contraction, endocrine diseases, neurodegenerative diseases, inflammation, pain, and drug abuse |
| 12/21/2010 | US7855207 such as 6-[(1R)-1-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-piperidin-1-ylpropyl]-3-ethyl-1H-quinolin-2-one, used for treating cancer and/or preventing cellular, tissue and/or organ damage resulting from cell damage or death due to, for example, necrosis or apoptosis |
| 12/21/2010 | US7855198 Benzamide derivative or salt thereof |